PharmaBoardroom spoke to Osvaldo Caro, President, Chairman and CEO of ReComS, about the legal side of the pharmaceuticals sector in Puerto Rico.…

In the past, the Moroccan pharmaceutical sector primarily served local needs. Now it is ramping up its research and development capabilities, looking…

Sevi Firat, Founding Partner of Firat Izgi discusses the legal challenges facing pharmaceutical companies looking to penetrate the healthcare market…

Mr. Lebrun discusses the role that BIOQuébec plays in the industry, its aims in representing several sectors and their plans for the coming years.

If there is one thing that successful Danish companies have in common with one another, it is the clear recognition of abundant opportunities outside…

Minister Marceau addresses the changes in policy in Quebec relating to the pharmaceutical and life sciences sectors, and the incentives in place to…

A perspective from Canada’s national health body on the future of medicine in the 21st century, from the shift to personalized medicine to…

A leading figure in the Taiwanese pharmaceutical sector, Lee divulges the practicalities behind ECFA, the free trade agreement that was signed between…

Under the administration of President Juan Manuel Santos, Colombia is focusing on bolstering the commercial sector. While this is good news for the…

BIOTECanada is the national trade association for Canada’s biotech industry. Andrew Casey, the group’s CEO, discusses the impact of IP regulation…

In Taiwan, GSK recently signed Memorandum of Understanding with the National Research Program of Biopharmaceuticals (NRPB), building on research…

Pia Olsen Dyhr is a member of the Danish Folketing (Parliament) for the Socialist People’s Party in the North Zealand greater constituency, as well…